This article is for educational purposes only. Semax and Selank are research peptides, not FDA-approved medications. Consult a licensed physician before use.
Both Semax and Selank were developed by the Institute of Molecular Genetics of the Russian Academy of Sciences — Semax in the 1980s, Selank in the 1990s. They were designed specifically to be stable, non-addictive peptide-based neurological drugs: Semax as a cognitive enhancer and neuroprotective agent, Selank as an anti-anxiety compound without the risks of benzodiazepines.
In Russia, both are registered pharmaceutical drugs available by prescription. In most Western countries they exist in a regulatory gray zone — research chemicals that have accumulated extensive human data through decades of clinical use in Eastern Europe.
They've entered the biohacking mainstream largely through the influence of Dave Asprey, Ben Greenfield, and Silicon Valley performance communities — where their uniquely clean cognitive profiles (no tolerance, no crash, no withdrawal) distinguish them sharply from conventional nootropics and stimulants.
| Full Name | Synthetic ACTH(4-7)PGP analogue |
|---|---|
| Mechanisms | Upregulates BDNF, NGF, and VEGF in brain; increases dopaminergic and serotonergic tone; enhances synaptic plasticity; neuroprotection via antioxidant pathways |
| Best For | Focus, working memory, cognitive clarity, BDNF-mediated neuroplasticity, post-stroke/TBI neuroprotection, motivation |
| Dose Range | 200–600 mcg intranasal per dose |
| Timing | Morning; can split into morning + early afternoon. Avoid evening — mildly activating. |
| Onset | 20–40 minutes intranasal |
| Duration | 4–8 hours cognitive effect; neuroplastic effects accumulate over days-weeks |
Semax is a heptapeptide analogue of ACTH(4-7) — the cognitively active fragment of adrenocorticotropic hormone — with a Pro-Gly-Pro sequence added to increase stability and CNS penetrance.
Its most significant and well-documented effect is dramatic upregulation of BDNF (Brain-Derived Neurotrophic Factor) — sometimes called "Miracle-Gro for the brain." BDNF is the primary driver of neuroplasticity: it governs the formation of new synaptic connections, the survival of existing neurons, and the brain's capacity to learn and adapt. BDNF levels decline with age, stress, poor sleep, and sedentary behavior — and this decline correlates strongly with cognitive aging.
Semax also increases dopaminergic tone in the prefrontal cortex — the region governing executive function, working memory, and goal-directed attention. This is the mechanism behind the sharp, clear-headed focus users describe as distinctly different from caffeine or amphetamine-based stimulants.
| Full Name | Synthetic tuftsin analogue (Thr-Lys-Pro-Arg-Pro-Gly-Pro) |
|---|---|
| Mechanisms | GABAergic modulation (similar to benzodiazepines but without receptor binding); BDNF upregulation; serotonin and enkephalin system modulation; anti-inflammatory cytokine reduction |
| Best For | Anxiety reduction without sedation, stress resilience, mood stabilization, sleep quality (evening dose), cognitive enhancement (synergistic with Semax) |
| Dose Range | 250–500 mcg intranasal per dose; 100–300 mcg SubQ |
| Timing | Morning for anxiety/cognitive use; can add evening dose for sleep quality |
| Onset | 15–30 minutes intranasal |
| Duration | 4–6 hours acute effect; anxiolytic effects accumulate over days |
Selank is a synthetic analogue of tuftsin — an endogenous immunomodulatory tetrapeptide. It modulates the GABAergic system — the same system targeted by benzodiazepines — but through a fundamentally different mechanism that produces anxiolysis without sedation, tolerance, or physical dependence.
This makes it categorically different from pharmaceutical anxiolytics. Users describe a quiet, stable calm — a reduction in background noise and rumination — without any blunting of cognition, motivation, or alertness. In clinical terms, it reduces state anxiety without affecting processing speed or executive function.
Selank also independently upregulates BDNF and modulates enkephalin metabolism — adding a complementary neuroplasticity mechanism that overlaps with Semax's effects and creates meaningful synergy in the stack.
Semax provides cognitive activation, BDNF-driven neuroplasticity, and dopaminergic focus. Selank provides anxiolytic smoothing and complementary BDNF support. The result is a cognitive state that users consistently describe as: "completely focused, no anxiety, no edge, no crash." This combination is particularly valued by professionals in high-stakes environments where both performance and composure are required simultaneously.
| Peptide | Beginner | Standard | Advanced | Timing |
|---|---|---|---|---|
| Semax | 200 mcg | 400 mcg | 600 mcg | Morning; optionally split AM + early afternoon |
| Selank | 250 mcg | 500 mcg | 500–750 mcg | Morning; can add 250mcg evening for sleep |
Both peptides have dose-dependent effects. Start at beginner doses for the first 3–5 days to assess individual response before increasing. Some users find 200mcg Semax + 250mcg Selank is their optimal dose — more is not always better with neuropeptides.
Both Semax and Selank are most commonly administered intranasally via nasal spray bottle. The nasal mucosa provides rapid absorption into systemic circulation and preferential CNS delivery via the olfactory-trigeminal pathway — bypassing the blood-brain barrier more effectively than most routes.
| Goal | Cycle | Notes |
|---|---|---|
| Cognitive enhancement / neuroplasticity | 3 weeks on / 1 week off | Most common protocol; prevents adaptation |
| Acute performance (exam, presentation) | Use as needed, up to 5 consecutive days | Take at least 2 days off between runs |
| Anxiety management (chronic) | Selank daily for 4–6 weeks; 2-week break | Selank can be used more continuously than Semax |
| Neuroprotection / post-TBI | Under physician supervision; longer cycles used clinically in Russia | Clinical use: 10–14 day intensive courses |
Both Semax and Selank have notably clean safety profiles — one of the primary reasons they've gained traction in biohacking communities despite being research peptides:
Add Lion's Mane (1,000–3,000mg/day) to this stack for additional NGF upregulation and complementary neurogenesis support. The triple combination — Semax + Selank + Lion's Mane — is the most comprehensive non-pharmaceutical cognitive enhancement stack currently available.
Technically possible but not recommended — you lose the ability to adjust doses independently, and stability data for combined solutions is limited. Use separate vials and administer a few minutes apart.
Semax's cognitive effects are typically felt within 30–60 minutes of intranasal administration. Selank's anxiolytic effect is often noticed within 20–40 minutes. The cumulative neuroplastic effects (improved baseline cognitive function, mood stability) develop over 1–3 weeks of consistent use.
Standard workplace and athletic drug tests do not screen for Semax or Selank. However, WADA (World Anti-Doping Agency) lists peptides as a prohibited class in some categories — competitive athletes should verify current WADA code applicability before use.
Long-term human safety data is limited but the available evidence (from decades of clinical use in Russia) is broadly reassuring. Most practitioners recommend cycling protocols (3 weeks on, 1 week off) as a precautionary measure and to prevent adaptation.
Log Semax, Selank, and your full cognitive protocol. Get interaction checking, personalized dosing schedules, and AI-powered optimization from the Health Intelligence Advisor.
Join the Waitlist →